MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, RCUS has $997M in assets. $201M in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
403.83%
Quick Ratio
403.83%
Cash Ratio
96.17%
Unit: Million (M) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Other noncurrent assets
    • Others
Liabilities Breakdown
    • Common stock and additional paid...
    • Accumulated deficit
    • Other noncurrent liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
201 222 238 248
Marketable securities
621 759 593 663
Receivable from collaboration partners
3 11 11 15
Prepaid expenses and other current assets
19 15 15 20
Total current assets
844 1,007 857 946
Long-term marketable securities
54 29 10 16
Property and equipment, net
38 40 42 44
Other noncurrent assets
61 63 65 69
Total assets
997 1,139 974 1,075
Accounts payable (11 and 24 to a related party)
39 42 42 29
Deferred revenue (27 and 35 to a related party)
34 35 52 71
Other current liabilities
136 154 141 110
Total current liabilities
209 231 235 210
Deferred revenue, noncurrent (36 and 43 to a related party)
45 43 53 60
Long-term debt
100 99 98 97
Other noncurrent liabilities
119 135 152 159
Common stock and additional paid-in capital 0.0001 par value per share 400.0 shares authorized 125.5 shares in 2026 and 125.3 shares in 2025 issued and outstanding
2,138 2,116 1,815 1,793
Accumulated deficit
-1,613 -1,485 -1,379 -1,244
Accumulated other comprehensive loss
-1 ---
Total stockholders equity
524 631 436 549
Total liabilities and stockholders equity
997 1,139 974 1,075
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$621M Cash and cashequivalents$201M Prepaid expenses andother current assets$19M Receivable fromcollaboration partners$3M Total current assets$844M Other noncurrentassets$61M Long-term marketablesecurities$54M Property and equipment,net$38M Total assets$997M Total liabilities andstockholders equity$997M Total stockholdersequity$524M Total currentliabilities$209M Other noncurrentliabilities$119M Long-term debt$100M Deferred revenue,noncurrent (36 and 43 to a...$45M Accumulated deficit-$1,613M Accumulated othercomprehensive loss-$1M Common stock andadditional paid-in capital...$2,138M Other currentliabilities$136M Accounts payable (11 and24 to a related...$39M Deferred revenue (27 and35 to a related...$34M

Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences, Inc. (RCUS)